| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.26 |
5e-06 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
7e-05 |